Cargando…
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national drug utilization study
AIMS: To estimate the incidence of direct oral anticoagulant drug (DOAC) use in patients with nonvalvular atrial fibrillation and to describe user and treatment characteristics in 8 European healthcare databases representing 6 European countries. METHODS: Longitudinal drug utilization study from Jan...
Autores principales: | Ibáñez, Luisa, Sabaté, Mònica, Vidal, Xavier, Ballarin, Elena, Rottenkolber, Marietta, Schmiedl, Sven, Heeke, Andreas, Huerta, Consuelo, Martin Merino, Elisa, Montero, Dolores, Leon‐Muñoz, Luz María, Gasse, Christiane, Moore, Nicholas, Droz, Cécile, Lassalle, Régis, Aakjær, Mia, Andersen, Morten, De Bruin, Marie Louise, Groenwold, Rolf, van den Ham, Hendrika A., Souverein, Patrick, Klungel, Olaf, Gardarsdottir, Helga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848911/ https://www.ncbi.nlm.nih.gov/pubmed/31318059 http://dx.doi.org/10.1111/bcp.14071 |
Ejemplares similares
-
Comparing risk of major bleeding between users of different oral anticoagulants in patients with nonvalvular atrial fibrillation
por: Souverein, Patrick C., et al.
Publicado: (2020) -
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008–2015)
por: Sabaté, M., et al.
Publicado: (2021) -
Major bleeding in users of direct oral anticoagulants in atrial fibrillation: A pooled analysis of results from multiple population‐based cohort studies
por: van den Ham, Hendrika A., et al.
Publicado: (2021) -
Sales of macrolides, lincosamides, streptogramins, and amoxicillin/clavulanate in the in- and outpatient setting in 10 European countries, 2007–2010
por: Ferrer, Pili, et al.
Publicado: (2015) -
Impact of anticoagulant exposure misclassification on the bleeding risk of direct oral anticoagulants
por: Hempenius, Mirjam, et al.
Publicado: (2021)